Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission.
Vigón L, Luna A, Galán M, Rodríguez-Mora S, Fuertes D, Mateos E, Piris-Villaespesa M, Bautista G, San José E, Rivera-Torres J, Steegmann JL, de Ory F, Pérez-Olmeda M, Alcamí J, Planelles V, López-Huertas MR, García-Gutiérrez V, Coiras M. Vigón L, et al. Among authors: piris villaespesa m. J Clin Med. 2020 Dec 25;10(1):42. doi: 10.3390/jcm10010042. J Clin Med. 2020. PMID: 33375572 Free PMC article.
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
García-Gutiérrez V, Milojkovic D, Hernandez-Boluda JC, Claudiani S, Martin Mateos ML, Casado-Montero LF, González G, Jimenez-Velasco A, Boque C, Martinez-Trillos A, Vázquez IM, Payer ÁR, Senín A, Amustio Díez E, García AB, Carrascosa GB, Ortí G, Ruiz BC, Fernández MÁ, Del Carmen García Garay M, Giraldo P, Guinea JM, De Las Heras Rodríguez N, Hernán N, Pérez AI, Piris-Villaespesa M, Lorenzo JLL, Martí-Tutusaus JMM, Vallansot RO, Ortega Rivas F, Puerta JM, Ramirez MJ, Romero E, Romo A, Rosell A, Saavedra SS, Sebrango A, Tallon J, Valencia S, Portero A, Steegmann JL; Grupo Español de Leucemia Mieloide Crónica (GELMC). García-Gutiérrez V, et al. Ann Hematol. 2019 Feb;98(2):321-330. doi: 10.1007/s00277-018-3507-2. Epub 2018 Nov 16. Ann Hematol. 2019. PMID: 30446802 Clinical Trial.
Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera.
Piris-Villaespesa M, Álvarez-Larrán A, Saez-Marín A, Nuñez-Torrón C, Muñoz-Martin G, Sánchez R, Del Castillo FJ, Villarrubia J, Lopez-Jimenez J, Martinez-Lopez J, Garcia-Gutierrez V. Piris-Villaespesa M, et al. Sci Rep. 2021 Jan 8;11(1):209. doi: 10.1038/s41598-020-80459-y. Sci Rep. 2021. PMID: 33420222 Free PMC article.
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Velázquez Kennedy K, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P. Núñez-Torrón Stock C, et al. Among authors: piris villaespesa m. Hematol Oncol. 2023 Oct;41(4):753-761. doi: 10.1002/hon.3160. Epub 2023 Apr 20. Hematol Oncol. 2023. PMID: 37081742
Bone marrow infiltration by flow cytometry at diffuse large B-cell lymphoma NOS diagnosis implies worse prognosis without considering bone marrow histology.
Martín-Moro F, Piris-Villaespesa M, Marquet-Palomanes J, García-Cosío M, Villarrubia J, Lario A, García I, Michael B, Roldán E, García-Vela JA, Lopez-Jiménez J. Martín-Moro F, et al. Cytometry B Clin Cytom. 2020 Nov;98(6):525-528. doi: 10.1002/cyto.b.21863. Epub 2019 Dec 24. Cytometry B Clin Cytom. 2020. PMID: 31873987 Free article.
Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore.
Núñez-Torrón C, Ferrer-Gómez A, Moreno Moreno E, Pérez-Mies B, Villarrubia J, Chamorro S, López-Jiménez J, Palacios J, Piris-Villaespesa M, García-Cosío M. Núñez-Torrón C, et al. Among authors: piris villaespesa m. J Clin Pathol. 2022 Jun;75(6):383-389. doi: 10.1136/jclinpath-2020-207337. Epub 2021 Mar 15. J Clin Pathol. 2022. PMID: 33722841
Usefulness of Omalizumab and Sting Challenge Test in Hymenoptera Venom Allergy and Mastocytosis.
González-de-Olano D, Padial-Vilchez MA, Núñez-Acevedo B, de-Calzada-Bustingorri MP, de-Andrés-Martín A, Caldas C, Piris-Villaespesa M, de-la-Hoz-Caballer B. González-de-Olano D, et al. J Investig Allergol Clin Immunol. 2019;29(4):318-320. doi: 10.18176/jiaci.0395. Epub 2019 Apr 8. J Investig Allergol Clin Immunol. 2019. PMID: 30957757 Free article. No abstract available.
Safety of COVID-19 vaccination in patients with clonal mast cell disorders.
Ruano-Zaragoza M, Carpio-Escalona LV, Diaz-Beya M, Piris-Villaespesa M, Castaño-Diez S, Muñoz-Cano R, González-de-Olano D. Ruano-Zaragoza M, et al. Among authors: piris villaespesa m. J Allergy Clin Immunol Pract. 2022 May;10(5):1374-1376.e3. doi: 10.1016/j.jaip.2022.01.030. Epub 2022 Feb 1. J Allergy Clin Immunol Pract. 2022. PMID: 35121156 Free PMC article. No abstract available.
22 results